Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development

Alzheimer’s disease is the most common type of neurodegenerative disease in the world. Genetic evidence strongly suggests that aberrant generation, aggregation, and/or clearance of neurotoxic amyloid-β peptides (<i>Aβ</i>) triggers the disease. <i>Aβ</i> accumulates at the po...

Full description

Bibliographic Details
Main Authors: Anatoly S. Urban, Konstantin V. Pavlov, Anna V. Kamynina, Ivan S. Okhrimenko, Alexander S. Arseniev, Eduard V. Bocharov
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/10/2897
_version_ 1827692628004569088
author Anatoly S. Urban
Konstantin V. Pavlov
Anna V. Kamynina
Ivan S. Okhrimenko
Alexander S. Arseniev
Eduard V. Bocharov
author_facet Anatoly S. Urban
Konstantin V. Pavlov
Anna V. Kamynina
Ivan S. Okhrimenko
Alexander S. Arseniev
Eduard V. Bocharov
author_sort Anatoly S. Urban
collection DOAJ
description Alzheimer’s disease is the most common type of neurodegenerative disease in the world. Genetic evidence strongly suggests that aberrant generation, aggregation, and/or clearance of neurotoxic amyloid-β peptides (<i>Aβ</i>) triggers the disease. <i>Aβ</i> accumulates at the points of contact of neurons in ordered cords and fibrils, forming the so-called senile plaques. <i>Aβ</i> isoforms of different lengths are found in healthy human brains regardless of age and appear to play a role in signaling pathways in the brain and to have neuroprotective properties at low concentrations. In recent years, different substances have been developed targeting <i>Aβ</i> production, aggregation, interaction with other molecules, and clearance, including peptide-based drugs. <i>Aβ</i> is a product of sequential cleavage of the membrane glycoprotein APP (amyloid precursor protein) by β- and γ-secretases. A number of familial mutations causing an early onset of the disease have been identified in the APP, especially in its transmembrane domain. The mutations are reported to influence the production, oligomerization, and conformational behavior of <i>Aβ</i> peptides. This review highlights the results of structural studies of the main proteins involved in Alzheimer’s disease pathogenesis and the molecular mechanisms by which perspective therapeutic substances can affect <i>Aβ</i> production and nucleation.
first_indexed 2024-03-10T11:26:43Z
format Article
id doaj.art-467b0090289a49c7a051faa36381a146
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T11:26:43Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-467b0090289a49c7a051faa36381a1462023-11-21T19:36:13ZengMDPI AGMolecules1420-30492021-05-012610289710.3390/molecules26102897Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease DevelopmentAnatoly S. Urban0Konstantin V. Pavlov1Anna V. Kamynina2Ivan S. Okhrimenko3Alexander S. Arseniev4Eduard V. Bocharov5Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, RussiaFederal Clinical Center of Physical-Chemical Medicine of FMBA, 119435 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, RussiaResearch Center for Molecular Mechanisms of Aging and Age-related Diseases, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, RussiaShemyakin–Ovchinnikov Institute of Bioorganic Chemistry RAS, 117997 Moscow, RussiaAlzheimer’s disease is the most common type of neurodegenerative disease in the world. Genetic evidence strongly suggests that aberrant generation, aggregation, and/or clearance of neurotoxic amyloid-β peptides (<i>Aβ</i>) triggers the disease. <i>Aβ</i> accumulates at the points of contact of neurons in ordered cords and fibrils, forming the so-called senile plaques. <i>Aβ</i> isoforms of different lengths are found in healthy human brains regardless of age and appear to play a role in signaling pathways in the brain and to have neuroprotective properties at low concentrations. In recent years, different substances have been developed targeting <i>Aβ</i> production, aggregation, interaction with other molecules, and clearance, including peptide-based drugs. <i>Aβ</i> is a product of sequential cleavage of the membrane glycoprotein APP (amyloid precursor protein) by β- and γ-secretases. A number of familial mutations causing an early onset of the disease have been identified in the APP, especially in its transmembrane domain. The mutations are reported to influence the production, oligomerization, and conformational behavior of <i>Aβ</i> peptides. This review highlights the results of structural studies of the main proteins involved in Alzheimer’s disease pathogenesis and the molecular mechanisms by which perspective therapeutic substances can affect <i>Aβ</i> production and nucleation.https://www.mdpi.com/1420-3049/26/10/2897Alzheimer’s diseaseamyloid precursor proteinamyloid-β peptidestructural–dynamical propertiestoxic oligomerizationmolecular mechanism
spellingShingle Anatoly S. Urban
Konstantin V. Pavlov
Anna V. Kamynina
Ivan S. Okhrimenko
Alexander S. Arseniev
Eduard V. Bocharov
Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
Molecules
Alzheimer’s disease
amyloid precursor protein
amyloid-β peptide
structural–dynamical properties
toxic oligomerization
molecular mechanism
title Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
title_full Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
title_fullStr Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
title_full_unstemmed Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
title_short Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
title_sort structural studies providing insights into production and conformational behavior of amyloid β peptide associated with alzheimer s disease development
topic Alzheimer’s disease
amyloid precursor protein
amyloid-β peptide
structural–dynamical properties
toxic oligomerization
molecular mechanism
url https://www.mdpi.com/1420-3049/26/10/2897
work_keys_str_mv AT anatolysurban structuralstudiesprovidinginsightsintoproductionandconformationalbehaviorofamyloidbpeptideassociatedwithalzheimersdiseasedevelopment
AT konstantinvpavlov structuralstudiesprovidinginsightsintoproductionandconformationalbehaviorofamyloidbpeptideassociatedwithalzheimersdiseasedevelopment
AT annavkamynina structuralstudiesprovidinginsightsintoproductionandconformationalbehaviorofamyloidbpeptideassociatedwithalzheimersdiseasedevelopment
AT ivansokhrimenko structuralstudiesprovidinginsightsintoproductionandconformationalbehaviorofamyloidbpeptideassociatedwithalzheimersdiseasedevelopment
AT alexandersarseniev structuralstudiesprovidinginsightsintoproductionandconformationalbehaviorofamyloidbpeptideassociatedwithalzheimersdiseasedevelopment
AT eduardvbocharov structuralstudiesprovidinginsightsintoproductionandconformationalbehaviorofamyloidbpeptideassociatedwithalzheimersdiseasedevelopment